FDA Panel Unanimously Recommends Authorization of Moderna COVID-19 Vaccine Booster

A Food and Drug Administration (FDA) advisory panel voted unanimously on Oct. 14 to recommend that the agency allow millions of Americans to get a booster shot of Moderna’s COVID-19 vaccine. The 19–0 vote came after hours of discussions and presentations in an all-virtual meeting. Moderna officials presented data from clinical trials, including a small trial that studied the safety and effectiveness of a booster shot, as did officials from Israel, one of the first countries in the world to start giving booster shots, and the FDA, which performed an analysis of Moderna’s data but didn’t support or oppose the company’s application for an emergency use authorization expansion. The FDA can overrule the panel’s recommendations but rarely does so. If the recommendation is approved, anyone aged 65 and older will be able to get a Moderna booster shot if they’ve received the primary two doses of the Moderna series. People …

Originally appeared on The Epoch Times

Read More